Metabolic Syndrome News and Research

Latest Metabolic Syndrome News and Research

Rimonabant appears to be very promising, especially for the treatment of patients with abdominal obesity

Overweight or obese people who are stout around the waist and abdomen are particularly at high risk for developing type 2 diabetes and high blood pressure.

30 Oct 2005

Strong social gradient in the metabolic syndrome

It is well documented that individuals with higher social status have lower risk of coronary heart disease (CHD). This is generally not explained by differences in lifestyle factors such as smoking and lack of exercise.

6 Sep 2005

Metabolic Syndrome, a map of the cardiovascular damage

The metabolic syndrome (MS) is a cluster of metabolic abnormalities with abdominal obesity (increased waist circumference) at its centre. Although all forms of obesity have a negative impact on human health, metabolic syndrome describes a set of particularly adverse biochemical changes accompanying (abdominal) obesity.

5 Sep 2005

Metabolic syndrome (MetS) in Europe

Previously, several different definitions for the metabolic syndrome (MetS) had been proposed and used by researchers. This resulted in confusion about the frequency of the MetS and its relationship with mortality.

5 Sep 2005

Call for closer examination of a metabolic syndrome

Two major health organizations in Europe and the United States are calling for closer examination of a syndrome that has been widely believed to predict the risk of developing heart disease, questioning whether it has been appropriately defined and whether it is in fact a syndrome at all.

25 Aug 2005

Weight control protein may yield new approaches for treating obesity and type 2 diabetes

The findings in mice further suggest that particular variants of the protein SH2-B might underlie obesity in humans, the researchers said.

16 Aug 2005

Researchers find drug targets for treating metabolic syndrome

Ongoing studies by researchers at UT Southwestern Medical Center and other institutions have uncovered the biochemical basis of many of the factors contributing to what is known as the metabolic syndrome, suggesting potential new drug targets for treating the condition.

11 Aug 2005

Power3 converts provisional patent applications

Power3 Medical Products announced today that it has converted two provisional patent applications by the filing of two utility patent applications with the United States Patent and Trademark Office for the Company's disease specific biomarker discovery and disease specific immuno- diagnostic test designs.

4 Aug 2005

Risk of metabolic syndrome raised even by secondhand smoke

A new study has shown that even secondhand smoke can raise the risk of metabolic syndrome, a condition marked by obesity, high blood pressure, unhealthy cholesterol levels and pre-diabetes.

4 Aug 2005

Signs of atherosclerosis seen in apparently healthy young adults

Young adults who seem to be healthy, but have a clustering of heart disease risks factors known as metabolic syndrome, tend to have signs of thickening of their carotid artery walls, which is an early indication of atherosclerosis, according to a new study in the Aug 2, 2005, issue of the Journal of the American College of Cardiology.

2 Aug 2005

Visceral obesity may be an important risk factor for insulin resistance syndrome in children

Waist circumference is associated with insulin resistance in children and may offer a simple way to identify children with risk factors for cardiovascular disease and type 2 diabetes, according to a study in the August issue of Archives of Pediatrics & Adolescent Medicine.

1 Aug 2005

Heart attack patients: shedding pounds reduces risks

Heart attack patients with diabetes or a cluster of cardiovascular risk factors known as metabolic syndrome have an increased risk of another heart attack, stroke or death, but patients who lost weight after their heart attacks were less likely to become diabetic, according to a new study in the July 19, 2005, issue of the Journal of the American College of Cardiology.

21 Jul 2005

Protein found in fat cells is a newly discovered cause of insulin resistance

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) has shown that a protein found in fat cells is a newly discovered cause of insulin resistance, establishing a previously unidentified molecular link between obesity and type 2 diabetes and offering a potential new target for the development of drugs to treat diabetes.

20 Jul 2005

Variant of a common protein plays a primary role in Type 2 diabetes and obesity

Scientists in France and the United States report that a variant of a common protein plays a primary role in Type 2 diabetes and obesity, key features of the "insulin resistance syndrome" that affects more than 50 million people in this country and a similar number in Europe.

19 Jul 2005

Metabolic syndrome prevented by a fit heart

According to a new study, a person's cardiorespiratory fitness is a strong predictor of their risk of developing metabolic syndrome.

12 Jul 2005

Obese men may not process carbohydrates as efficiently as obese women

Obese men may not process carbohydrates as efficiently as obese women, a condition that can, ultimately, lead to a decrease in fitness level and the development of metabolic disorders.

12 Jul 2005

Obese men may not process carbohydrates as efficiently as obese women

A new study published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), showed that severely obese men were more carbohydrate intolerant and had less physical endurance than severely obese women, leading researchers to believe that gender plays a strong role in physical fitness and a person's ability to metabolize carbohydrates.

11 Jul 2005

Low dose birth control pill raises heart attack risk, especially in some women

A new review suggests that low-dose birth control pills, which are generally considered to be safer than the pill of the past, still carries an increased risk for heart attack and stroke.

11 Jul 2005

Europe tackles pre-diabetes

Diabetes is the fourth leading global cause of death and, with over 60 million people in Europe already estimated to have pre-diabetes, the situation is set to escalate at an alarming rate unless urgent action is taken.

29 Jun 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005